Skip to content
Search AI Powered

Latest Stories

Videos

Niambe McIntosh on the Tosh Foundation, Her Father's Legacy & More | Flow State Friday
Bluntness Media
Culture

The Flow State: Niambe McIntosh on the Tosh Foundation, Her Father's Legacy & More

If you’ve never listened to the music of Peter Tosh, if you’ve never done the deep dive – you owe it to yourself to do that now.

Pull up a YouTube mix, hit shuffle on Spotify, read the man’s bio – you will immediately connect yourself into the vortex of the cannabis freedom spirit.


Most people know him as the stern-looking bandmate who left Bob Marley and the Wailers and went on to record the 1976 cannabis activist anthem “Legalize It”.

Peter ToshPeter Tosh would have turned 77 in October 2021.Images courtesy of Tosh Holdings LLC

These are broad strokes for sure. And the real story of Peter Tosh deserves so much more attention than that, no matter your interest in cannabis or reggae.

Spreading and growing the Peter Tosh legacy has become the mission of Niambe McIntosh, Tosh’s youngest child.

Today, McIntosh is head of the Peter Tosh Estate and Brand, Tosh Holdings, in addition to the Peter Tosh Foundation, which focuses on legalization, social justice, cannabis education, as well as the Peter Tosh Museum.

Listen to the full interview with Niambe McIntosh here:

Paying Dearly for Cannabis Freedom

“You google his name now, and you see him with a spliff in his hand, in his mouth, in just about every picture. But many people don't know that he suffered a lot because of that,” McIntosh told The Bluntness. 

In John Masouri’s 2013 unauthorized biography Steppin' Razor: The Life of Peter Tosh, one can read all sorts of harrowing cannabis stories, including one where he reportedly lit up in the middle of a flight.

Tosh believed he had a natural right to cannabis, and nobody was going to stop him from consuming wherever and whenever he pleased (and he hated cigarette smoke).

Peter Tosh in a cannabis fieldPeter Tosh was an original activist for cannabis during the '70s and '80s, no matter the cost.Courtesy of Tosh Holdings LLC

However, most people don’t know that Tosh was beaten by the Jamaican police for cannabis on a regular basis, sometimes in his own home or yard.

Not long after the One Love Peace Concert in 1978, where Tosh infamously sparked a spliff on stage in front of the Prime Minister, the police arrested Tosh for cannabis possession. And they beat him savagely, nearly to death. In fact, they only stopped when Tosh actually pretended to be dead.

“People assume that, Oh, you know, you can walk around in Jamaica just fine [with cannabis]. But he was a target, and so it wasn't an easy task, it was something that he truly did fight for and wanted to be the exemplar – cannabis being his human right to consume a plant that he knew was medicinally and spiritually beneficial.”

Tosh did not let the police beating injuries slow him down, nor the setbacks, the car accidents, the death of friends – he worked through the pain, recording new songs and albums. Today, decades later, the potency of his music is greater than ever, a message carried by rhythms and instrumentation that will ease the factures in your heart, if you let it.

Tosh’s life and work serve as a microcosm of humankind’s relationship with the herb. Suffering for cannabis freedom, cannabis as a sacrament, cannabis as a means for human connection, for healing, for creative inspiration, for balance, a medicinal remedy to help us navigate the terrible beauty of life.

A History of Violence on Repeat

The targeted brutality Tosh experienced for his cannabis use is by no means an isolated case. For decades, People of Color have been disproportionately targeted and punished for cannabis, particularly in the U.S. but other countries as well.

Tosh’s youngest son, Jawara Tosh – tragically lost his life to the so-called war on drugs, after he was arrested for cannabis possession in New Jersey and later beaten into a coma while incarcerated.

Jawara, a father and talented musician in his own right (performing under the moniker Tosh 1), spent more than three years fighting for life, his brain never the same.

In July 2020, Jawara succumbed to his injuries, passing away – yet his story remains, a story which, like his father’s, McIntosh continues to share “so that no other family can have to go through what we've gone through, and so that people can understand when we look at ways to support those that have been impacted by the war on drugs, it can't just be one or two people getting into the cannabis industry,” she said. 

“It really has to look like reparations within the Black community; it has to look like programming for children; it has to look like therapy; we have to think way outside of the box to really right the wrongs and start to heal from the damage that has been done.”

Celebrating the Life and Legacy of Peter Tosh

Every year on April 20, cannabis lovers unite to celebrate their favorite plant – yet something is missing from this holiday, something to give it true substance and meaning.

After all, for many cannabis aficionados, every day is 420, right?

In 2021, McIntosh and team commemorated April 20 as International Peter Tosh Day through a virtual music festival.

Peter ToshInternational Peter Tosh Day was commemorated on April 20, 2021.Courtesy of Tosh Holdings LLC

As a life-long cannabis advocate who has recently become deeply familiar with the life and work of Peter Tosh, yours truly cannot think of a more apropos designation for the annual cannabis holiday. 

International Peter Tosh Day adds a sense of purpose and meaning to 4/20 that simply isn’t there otherwise.

How many people getting stoned to “Legalize It” actually know about the darker parts of Tosh’s life? The cannabis brutality, the tragic accidents, the perseverance … it was Tosh’s song that helped give rise to cannabis activism.

And while many people saw Tosh’s Rasta Warrior presence as militant, he was truly quite the opposite. He only wanted freedom.

“Although people see him in media, and knew his public persona to be very serious, he was actually a very fun-loving individual and very kind,” McIntosh said, adding that he’d taught himself to play over 20 instruments. “My mom used to say that if you're hanging around with him, you’re just laughing all day.” 

He was charismatic and liked to joke a lot, she continued. He would even ride a unicycle on stage.

“He liked to always give people around him opportunities to make a little bit of money, and he’d always share his ganja. He was a kind, kind soul, and I think that's something that many people didn't see in the public eye.” 

Need a little more Bluntness in your life? Sign Up for our newsletter to stay in the loop.

Up Next

The Intersection of LGBTQ+ Advocacy and Cannabis Legalization
The Intersection of LGBTQ+ Advocacy and Cannabis Legalization
The Intersection of LGBTQ+ Advocacy and Cannabis Legalization
Editorial

LGBTQ+ & Cannabis: Power Duo

From Stonewall to dispensary laws, queer advocacy helped legitimize cannabis as medicine and ignited a broader movement for justice, health, and dignity. Their impact is visible in today’s ongoing progress toward cannabis access and LGBTQ+ rights.

Over the past 50+ years, LGBTQ+ communities around the world have fought tirelessly for their rights and equality. From the watershed moment of the Stonewall Riots in 1969 to the ongoing push for trans rights and protections, LGBTQ+ history is a narrative of both triumph and adversity.

Alongside this ongoing journey, an unexpected yet powerful alliance has taken root between the LGBTQ+ movement and the push for cannabis legalization. This shared struggle for civil liberties, health equity, and dignity has produced some of the most consequential advocacy in modern U.S. history. Queer activists were among the earliest and most vocal champions of medical cannabis—particularly during the HIV/AIDS crisis—and their work continues to shape both movements today.

From Stonewall to Street Activism: The Rise of LGBTQ+ Advocacy

a group of people walking on a sidewalk in front of a the Stonewall Inn in NYCFrom Stonewall to Street Activism: The Rise of LGBTQ+ Advocacy - The Bluntness Photo by Karly Jones on Unsplash

The modern LGBTQ+ rights movement traces its roots to the early hours of June 28, 1969, at the Stonewall Inn in New York City. When police raided the gay bar in the Greenwich Village neighborhood, LGBTQ+ patrons—many of them transgender people and people of color—fought back. The ensuing protests became a galvanizing force for queer activism.

Among the most prominent figures was Marsha P. Johnson, a Black transgender activist and co-founder of Street Transvestite Action Revolutionaries (STAR), which supported LGBTQ+ youth and sex workers. Stonewall became not only a symbol of resistance but also a template for how marginalized communities could organize to demand justice.

The AIDS Crisis and the Emergence of Medical Marijuana Advocacy

In the 1980s and '90s, the LGBTQ+ community faced a devastating new battle: the HIV/AIDS epidemic. With the federal government slow to respond, queer communities—particularly in San Francisco—mobilized to care for their own.

Amid the despair, cannabis emerged as a life-saving alternative medicine. People living with HIV/AIDS found that marijuana alleviated symptoms like chronic pain, nausea, and severe appetite loss. Dennis Peron, a gay Vietnam veteran and close ally of Harvey Milk, founded the San Francisco Cannabis Buyers Club, the first public dispensary in the United States. Peron's advocacy laid the foundation for California's Proposition 215, the groundbreaking 1996 Compassionate Use Act that legalized medical marijuana.

Another key figure was "Brownie Mary" Rathbun, an elderly hospital volunteer and cannabis activist who baked marijuana brownies for AIDS patients. Her arrest and ensuing media attention helped turn public opinion in favor of compassionate cannabis use.

A Medical Turning Point: Epidiolex and the FDA

The LGBTQ+ community’s leadership in medical marijuana advocacy helped fuel scientific research and pharmaceutical interest. In 1997, nurse and cannabis advocate Mary Lynn Mathre published a manifesto on marijuana’s medical benefits. Her work influenced Dr. Geoffrey Guy, founder of GW Pharmaceuticals, which would go on to develop Epidiolex—a CBD-based medication for rare seizure disorders. The FDA’s approval of Epidiolex in 2018 marked the first federally approved cannabis-derived drug, offering legitimacy to a movement that began with grassroots LGBTQ+ activism.

Cannabis and HIV Treatment: Relief, Compassion, and Advocacy

Cannabis remains an essential tool in HIV symptom management. Antiretroviral therapy (ART) remains the gold standard for controlling HIV and preventing its progression to AIDS, but it can cause debilitating side effects, including nausea, neuropathy, and appetite suppression. Medical marijuana has helped mitigate these effects, offering patients greater comfort and improving quality of life.

Studies continue to explore cannabis's anti-inflammatory properties and potential to support immune system health, although it is not a substitute for ART. Patients considering cannabis as a complementary therapy should consult healthcare providers, as interactions with medications can vary.

The Ongoing Fight: Discrimination, Legislation, and Social Justice

While significant progress has been made—such as the declassification of homosexuality as a mental disorder in 1973 and the Supreme Court’s legalization of same-sex marriage in 2015—discrimination persists. The 2019 ban on transgender military service members, since reversed, is one such example.

At the same time, cannabis remains federally illegal in the U.S., creating a patchwork of state-level laws that range from full legalization to strict prohibition. Ballot measures have been instrumental in legalizing medical and recreational cannabis, often with provisions for retail sales, home cultivation, and social equity programs. However, federal law still classifies marijuana as a Schedule I drug, exposing users and entrepreneurs to potential prosecution.

Shared Struggles, Shared Strength

Both the LGBTQ+ and cannabis legalization movements stem from a common origin: the resistance of marginalized communities against unjust systems. From street protests outside Stonewall to the quiet dignity of an AIDS patient finding relief in a cannabis edible, the story is one of resilience, compassion, and courage.

The approval of medical cannabis products like Epidiolex and the continued legalization efforts across the country would not have been possible without the early activism of LGBTQ+ individuals. Their legacy endures in every ballot passed, every dispensary opened, and every patient relieved from suffering.

As the fight for both queer liberation and cannabis justice continues, it’s essential to recognize their deep historical connection—and to honor those who risked everything to push society forward.


​Top LGBTQ Cannabis Brands 

Hey Flamer 

Founded by queer activists Wyatt Harms and Matías Alvial, FLAMER is more than a cannabis brand—it's a cultural movement. Known for hosting inclusive events, FLAMER emphasizes community and queer joy. In 2025, they collaborated with drag icon Sasha Colby to launch the "Sasha Colby Kush," an indica hybrid pre-roll designed for relaxation and anxiety relief. Available in NY.

Meta's Censorship Circus: Cannabis and Psychedelics Face the Axe While Sex and Violence Get the Thumbs Up
Editorial

Meta's Circus: Drugs Censored, Sex Approved

Despite growing legalization and scientific support, Meta continues to target cannabis and psychedelics accounts with shadowbans and takedowns—while letting sexually explicit and violent content thrive unchecked on Instagram.


Instagram has long touted itself as a community-safe, family-friendly platform—but that claim rings hollow for cannabis and psychedelics advocates who’ve watched their educational, legal, and medically backed content get flagged, shadowbanned, or permanently erased. Meanwhile, videos glorifying violence and sexual exploitation flood Explore pages like sponsored content from hell.

This isn’t content moderation. It’s targeted censorship masquerading as public safety.

The Crackdown Continues: Now Psychedelics Are in the Crosshairs

Over the past few weeks, Meta has quietly suspended numerous psychedelics-related accounts, including institutions like the U.C. Berkeley Center for the Science of Psychedelics and community groups like Moms on Mushrooms. Accounts have been banned, reinstated, and banned again—with little explanation, no transparency, and certainly no accountability.

Even when Meta finally admits it “made a mistake,” as it did after banning the Instagram accounts for Psychedelic Science and the Psychedelic Assembly, it offers little comfort. As founder Kat Lakey put it: “I’m relieved, but also nervous about posting anything psychedelic-related right now in case it causes the account to get deleted again.” Translation: Post at your own risk, even if it’s legal, medically relevant, or part of public discourse.

This kind of whiplash enforcement is beyond punitive—it’s a chilling message: If you’re talking about cannabis or psychedelics, you’re never truly safe on Meta’s platforms, even when you're doing everything by the book.

Meta’s Message: Legally Sanctioned Plant Medicine Is Dangerous, But Booty Pics and Brawls Are Fine

What makes all this so infuriating is not just the censorship—it’s the flagrant double standard. Instagram is perfectly fine pushing half-naked influencers and hyper-violent content to its 2.4 billion users. Its algorithm rewards rage, sex, and spectacle. You’ll never see a “community guideline violation” for an account that posts exploitative thirst traps or fight compilations. But if you post about microdosing for PTSD? Deleted.

The hypocrisy is staggering. Meta claims its cannabis and psychedelics policies exist to “keep the community safe.” Meanwhile, a Wall Street Journal report found that Instagram hosted ads for cocaine and opioids—content that’s not just “unsafe,” but outright illegal.

Let that sink in. Meta profits off clickbait pushing dangerous narcotics, but will permanently ban a mother sharing her experience with psilocybin for postpartum depression.


Let’s be clear—this is not a critique of body positivity. There’s absolutely nothing wrong with people celebrating their bodies or expressing themselves authentically. But the content dominating Instagram’s algorithm isn’t just body-positive—it’s sexually explicit, often skirting the edges of pornography, and in some cases, blatantly crossing the line.

These aren’t empowering posts about self-love; they’re sexually-explicit content engineered for clicks, engagement, and sexual gratification, often pushed to young users via Explore feeds and recommendation algorithms. The fact that this kind of material gets algorithmic amplification while legal, educational cannabis or psychedelics content gets buried or banned shows exactly where Instagram’s priorities lie.

Real Harm, Real Costs

Instagram’s erratic, opaque moderation isn’t just an inconvenience—it’s a serious economic and social liability for small businesses, researchers, and advocacy organizations. For cannabis dispensaries and psychedelic educators, Instagram is often the single most important channel for reaching adult consumers. When that gets shut down, it’s not just a hit to engagement—it’s a hit to livelihoods.

Gina Vensel, co-founder of the Plant Media Project, has already collected nearly 60 cases of psychedelic accounts being removed or shadowbanned—most with vague, copy-paste justifications that cite “community guidelines” but explain nothing.

This level of inconsistency—where enforcement is algorithmic, appeals are arbitrary, and punishment is more severe for cannabis content than softcore porn or digital street fights—makes one thing crystal clear: Meta’s concern isn’t user safety. It’s optics. And cannabis and psychedelics are easier to scapegoat than sex or violence, which drive far more engagement.


The Real Problem: Algorithmic Idiocy and Cultural Lag

At the core of this chaos is Meta’s lazy reliance on AI-powered moderation. These bots can’t tell the difference between a research abstract on psilocybin and a crack dealer’s come-up reel. As a result, the system overcorrects, targeting legitimate voices while letting the algorithm-juicing shock content slide right through.

Worse, the policies underpinning this enforcement are rooted in outdated, prohibition-era stigmas that haven’t caught up to the laws or the science. Cannabis is legal for medical or recreational use in dozens of states and countries. Psychedelics are being studied—and in some places decriminalized—for their therapeutic potential. But Meta still treats all of it like black-market contraband.

Time to Cut the Crap

Instagram can’t have it both ways. You can’t claim to be a platform for community, culture, and education while silencing some of the most impactful conversations in health and science—just because they don’t fit your ad-safe narrative.

If Meta is serious about building trust, it needs to start with three things:

  1. Transparency – Clearer guidelines and explanations when accounts are flagged.
  2. Consistency – If you’re going to police cannabis and psychedelics, you better be policing sex and violence with the same energy.
  3. Human Oversight – AI isn’t cutting it. Content with medical, scientific, or cultural relevance needs real review—not bot-triggered bans.

Until then, cannabis and psychedelics will remain second-class citizens in Meta’s digital empire—legal offline, but treated like contraband online. And that’s not just hypocritical. It’s dangerous.



exhibitor at Revelry Buyers Club selling their wares
Hive & High, a new artisanal THC honey gummy launching at Revelry Hudson.
Hive & High, a new artisanal THC honey gummy launching at Revelry Hudson.
Featured

Revelry Buyers' Club Proves New York’s Cannabis Industry Is Finally Hitting Its Stride

Three years after legalization, New York’s cannabis market is finally finding its footing — and Revelry Buyers’ Club continues to be the connective tissue helping to fuel its success.

If you want to understand the state of New York’s legal cannabis industry, look no further than the most recent Revelry Buyers’ Club, held May 14 at Basilica Hudson. What began as a scrappy, community-led gathering has evolved into the beating heart of New York’s cannabis ecosystem — equal parts marketplace, cultural convening, and movement accelerator.

This year’s Revelry event brought together more than 300 licensed retailers and 200+ brands, cultivators, processors, and service providers under one roof. That alone is evidence of progress in a state whose rollout was once (and some would say, is still) defined by delays, lawsuits, and bureaucratic gridlock. But more importantly, the event underscored a deeper truth: the New York cannabis industry is alive, evolving, and driven by a complex mix of grit, collaboration, innovation and ambition.

From Chaos to Cohesion: A Market Coming Into Focus

New York’s cannabis rollout has been anything but smooth. Between regulatory uncertainty, a slow licensing process, and rampant unlicensed retail activity, stakeholders have had to navigate an unpredictable landscape. Yet, against all odds, the community has persisted — and grown.

Revelry Buyers’ Club stands as proof. What started as a response to market dysfunction has matured into a vital B2B platform for New York’s cannabis operators to build relationships, ink deals, and share ideas. Unlike trade shows that focus solely on commercial transactions, Revelry weaves together culture, commerce, and community — honoring the unique character of New York’s blossoming cannabis scene.

You’ll find Multi-State Operators (MSOs) like Fernway, Kiva Confections, Wana Brands, and more, with expansive marketing budgets exhibiting alongside family-run cultivators from all across the state such as Nanticoke, FLWR CITY, Ayrloom, social equity brands such as 40 Tons, Happy Munkey, Torches, and first-time cannabis entrepreneurs such as Hive & High and Reform Botanicals who are just getting their SKUs shelf-ready. It’s an ecosystem in real time — rough around the edges but undeniably dynamic - just like New York.

​Images from Revelry Buyers Club @ Basilica Hudson 2025

Hive & High, a new artisanal THC honey gummy launching at Revelry Hudson.

A Growing Market with a Point to Prove

Legal cannabis in New York is still in its adolescence, but the trajectory is promising. There are currently 381 licensed retail dispensaries open throughout the state with new licensed dispensaries opening monthly. Cultivators are refining their harvests. Brands are diversifying and innovating. Consumers are educating themselves. And events like Revelry are catalyzing the kind of connections that help this industry inch closer to legitimacy, sustainability, and long-term impact.

The stakes are high. This is more than just business — it’s about righting historical wrongs, unlocking economic opportunity, and creating an industry that looks and feels different than the one built in other states.

And while MSOs bring operational muscle and funding, it’s the grassroots operators — the family-owned cultivators, community-focused retailers, and legacy-to-legal founders — who keep the soul of the New York market alive. They’re betting on this industry not just to make money, but to make change.

Will "Outsiders" Make Inroads Here in New York

This October, Hall of Flowers — the original high-profile California B2B cannabis trade show — will host its first New York event at Pier 36 in Manhattan. Its arrival is a signal that the broader, national cannabis industry is finally taking New York seriously. The event will offer a polished, curated experience that connects brands and retailers through product discovery and business development.

But while Hall of Flowers brings production value and scale, many believe it will struggle to replicate the cultural authenticity and connective tissue that makes Revelry Buyers’ Club such a critical part of New York’s cannabis infrastructure. The difference is more than aesthetic — it’s foundational.

The Path Forward: Normalization, Hustle, and Hope

The cannabis industry in New York — like much of the country — still operates in a federally restricted limbo. Banking challenges, tax burdens, and interstate commerce barriers remain. Descheduling cannabis at the federal level would be a game-changer. But until that day comes, New Yorkers will do what they’ve always done: hustle, innovate, and build by any means necessary. We are unstoppable.

Revelry Buyers’ Club has become more than an event — it’s a catalyst. It reflects the resilience and ingenuity of a community that refuses to wait for permission to build something better.

As the market matures, one thing is clear: this is no longer just about legal weed. It’s about creating an industry rooted in equity, culture, creativity, and sustainable growth. And at the center of it all is Revelry — showing what’s possible when business meets community, and hustle meets heart.

image of the inside of the new Travel Agency dispensary in SoHo NYC.
The Travel Agency Lands in SoHo — A Cannabis Retail Experience That Doubles as a Gallery
The Travel Agency Lands in SoHo — A Cannabis Retail Experience That Doubles as a Gallery
Editorial

The Travel Agency Lands in SoHo

Where High Design Meets Higher Consciousness: Inside the City's Most Art-Forward Dispensary Yet

In a city packed with dispensaries, The Travel Agency isn’t just selling weed—it’s curating wonder. And with its latest destination at 598 Broadway, right in the heart of SoHo, the brand doubles down on its mission to elevate cannabis retail into an immersive, sensory, and cultural experience.


image of cannabis edibles on display at Travel Agency's newly opened SoHo dispensaryThe Travel Agency Lands in SoHo - The Bluntness

Following the successful launch of locations in Union Square, Downtown Brooklyn, and Fifth Avenue, The Travel Agency’s SoHo debut isn’t just another store opening—it’s a statement. A design-forward, community-conscious, and artistically driven statement that puts cannabis at the center of New York’s contemporary culture conversation.

A Storefront Designed to Stop You in Your Tracks

exterior image of Travel Agency's new SoHo dispensary storefront. The Travel Agency Lands in SoHo - The Bluntness

If the Union Square location felt like a portal to enchantment, the new SoHo dispensary is a full-on art installation disguised as retail. Created in partnership with visionary firm Leong Leong Architecture, the store draws inspiration from the experimental art spaces of downtown’s heyday (and from the now shuttered The House of Cannabis - THCNYC - just a few blocks south - IYKYK). Think minimalist futurism meets a luxury travel lounge.

The space features a glowing, arched ceiling that casts soft light over a constellation of glass vitrines, where cannabis products are displayed more like rare artifacts than retail items. The result? A shopping experience that feels more MoMA than marijuana.

Custom fabrication by Big Heavy Studios brings a tactile edge, creating sculptural shelving and installations that celebrate cannabis as a legitimate medium of creative expression. The final flourish? A kinetic, data-driven art piece by BREAKFAST Studio that pulses with real-time movement, mirroring the ever-shifting energy of the city.

The Bong Gallery: Where Function Meets Fine Art

One of the store’s most buzzworthy features is the Bong Gallery, a curated collection of high-design glassware that blurs the line between ritual and sculpture.

On display: psychedelic, color-soaked bongs from Milan-based designer Serena Confalonieri, alongside Juan Manuel Carmona’s surrealist OLMi Bong—a piece as thought-provoking as it is functional, layered with humor, political critique, and Mexican cultural symbolism.

This isn’t about novelty. It’s about narrative. Each piece invites the consumer to reconsider what cannabis culture can look and feel like in a new era.

interior image of Travel Agency's new SoHo retail, featuring a wall of glass bongsThe Travel Agency Lands in SoHo - The Bluntness

More Than a Dispensary—A Destination for Cultural Travelers

“From Keith Haring to Basquiat, SoHo has always been a playground for boundary-pushers,” says Arana Hankin-Biggers, Co-Founder and CEO of The Travel Agency. “This store is a tribute to that legacy—an invitation to explore cannabis through the lens of art, design, and social change.”

Like its sister locations, The Travel Agency SoHo operates under New York’s Social and Economic Equity (SEE) program. As a BIPOC-founded company, the brand continues to reinvest in local communities while fighting to dismantle the legacy harms of the War on Drugs. This isn’t lip service; it’s baked into their business model.

And let’s not forget: The Travel Agency isn’t just catching the media’s eye—it’s shaping the narrative. The brand has racked up Clio Awards, landed in The New York Times and People Magazine, and even made waves as the first cannabis brand to sponsor the New York Film Festival and a Met Gala after-party.

Interior image of Travel Agency's new SoHo dispensaryThe Travel Agency Lands in SoHo - The Bluntness


A New Standard for Cannabis Retail

The SoHo launch cements what many already knew: The Travel Agency is setting the new gold standard for cannabis retail. This isn’t about jumping on trends. It’s about redefining them.

Whether you’re a curious first-timer or a seasoned aficionado, walking into The Travel Agency SoHo isn’t just about buying cannabis—it’s about traveling somewhere new. Somewhere artful. Thoughtful. High-end. And high-minded.

The SoHo location is now open at 598 Broadway, with a grand opening celebration slated for May 28, 2025.

gif of actor Kevin James from King of Queens; asking "How Much Does That Cost?"
Why Is Some Weed More Expensive Than Others? Understanding Cannabis Pricing
Giphy
News

Unraveling Cannabis Pricing: Factors Behind the Cost of Weed

From Budget Buds to Premium Flower: Inside the Complex Economics of Cannabis Pricing and What It Means for Your Wallet.


Step inside a cannabis dispensary for the first time and the experience can be overwhelming. The meticulously labeled glass jars showcase dozens of strains with names like "Wedding Cake" and "Blue Dream," while refrigerated cases display concentrates, edibles, and tinctures at wildly different price points. Unlike the days when consumers were limited to whatever their neighborhood dealer offered, today's legal market presents a dazzling array of options that might leave newcomers with both wonder and sticker shock.

One thing customers notice immediately: not all cannabis is priced equally. A gram of one strain might cost an affordable $4 while another could command premium prices that seem puzzlingly high. This price disparity raises questions for both newcomers and experienced consumers alike. Is expensive weed worth it, or are you simply paying a "hype tax"?

The Economics Behind Cannabis Pricing

The cannabis industry operates under unique market conditions shaped by several interconnected factors:

Federal Regulations and Their Ripple Effects

Despite growing state-level legalization, the federal government's classification of marijuana as a controlled substance creates complications that directly impact pricing:

  • Banking restrictions force many businesses to operate cash-only, increasing security costs
  • Interstate commerce prohibition prevents efficient supply chain optimization
  • Tax code section 280E prevents cannabis businesses from deducting ordinary business expenses, significantly increasing their effective tax rates

A 2023 industry analysis estimated these federal constraints add 30-40% to operational costs compared to similar retail businesses. When combined with state-specific licensing fees that can reach into hundreds of thousands of dollars annually, these regulatory hurdles create substantial overhead costs that inevitably get passed to consumers.

Cultivation Methods Matter

The way cannabis is grown dramatically affects both its quality and price:

Indoor cultivation requires substantial investment in specialized equipment—lighting systems, climate control, ventilation, and precise nutrient delivery systems. These controlled environments allow for year-round growing with consistent results but at higher production costs.

Outdoor cultivation harnesses natural sunlight and soil, drastically reducing production costs. However, outdoor grows are subject to seasonal limitations, weather risks, and typically produce one or two harvests annually.

Greenhouse and mixed-light cultivation offers a middle ground, using natural sunlight supplemented with artificial lighting while providing some environmental controls.

John Kaye, co-founder of cannabis retailer Burb, explains that cultivation method directly impacts the final product: "The nose (does it smell pungent/pleasant?), color (look for vibrant green buds with orange/red hairs), feel (is it sticky, dense?), burn (how clean does it smoke?)—these qualities often correlate with production methods."

image of an indoor commercial green house growing cannabisWhen it comes to pricing, cultivation methods matter - The Bluntness Photo by Richard T on Unsplash

Quality Indicators and Their Price Impact

Several factors signal premium cannabis that commands higher prices:

  • Cannabinoid profile: While THC percentage remains a key pricing factor, the industry is increasingly recognizing the value of balanced cannabinoid profiles and diverse terpene content. Premium products often feature precise ratios of THC, CBD, CBG, and other cannabinoids targeted for specific effects.
  • Terpene preservation: These aromatic compounds not only create the plant's distinctive scents but significantly influence its effects through what scientists call the "entourage effect." Premium cultivation and processing methods preserve these delicate compounds.
  • Appearance: Properly cultivated, trimmed and cured cannabis displays vibrant colors, visible trichomes (the crystal-like structures containing cannabinoids), and proper moisture content without being too dry or too damp.
  • Proper curing: This meticulous post-harvest process can take 2-8 weeks as opposed to rushed methods that might take just days. Proper curing preserves cannabinoids and terpenes while removing chlorophyll and other compounds that create harsh smoke.
  • Clean cultivation: Premium products increasingly emphasize organic growing methods that avoid harsh pesticides, producing a cleaner final product. Lab testing verifies not just potency but the absence of contaminants, molds, or chemical residues.

The Brand Factor

Like other consumer goods, branding significantly influences cannabis pricing. An anonymous former dispensary inventory manager in Colorado (whom we'll call Keith) revealed: "Some growers get a name for themselves and raise prices accordingly. Customers are at times paying more for the grower's reputation than the objective quality of their product."

This aligns with broader retail principles. "It's all about the same things as prices in any other business: the profit they hope to gain based on what it costs them to have the product, and customer perceptions of what is worth that price," Keith explained.

Local Market Dynamics

Cannabis pricing also responds to local market conditions:

  • Market maturity: Newer legal markets typically have higher prices that gradually decline as more businesses enter the space and production capacity increases.
  • Taxation structure: State and local cannabis taxes vary dramatically, from modest to punitive, directly affecting final consumer prices.
  • Competition density: Areas with numerous dispensaries typically see more competitive pricing than those with limited retail options.

The Consumer Perspective

Cannabis consumers navigate these pricing factors differently based on their priorities and experience levels.

Some, like 38-year-old Colin, believe quality differences justify price premiums: "Those differently priced strains probably don't look the same or smell the same. There are probably large quality differences in the final product that account for the price difference."

Others approach the market more skeptically. Corey, a 34-year-old dance instructor from Chicago, suggests high prices sometimes exploit novice consumers: "The average person is exactly who dispensaries want coming through those doors because they can tell you weed will give you energy and you'll believe them for some reason."

Many consumers find themselves balancing budget with quality preferences. "The cheap stuff ruins my throat. The good stuff ruins my wallet," one consumer told us. "The fact that we can get it legally, though, is priceless."

Navigating Price vs. Value: A Consumer Guide

For consumers seeking to maximize value, industry experts recommend considering:

  1. Personal tolerance and needs: Higher-potency products might provide better value for experienced consumers despite higher upfront costs. If 10mg of THC produces your desired effect, a $40 product with 200mg total THC (20 doses) may offer better value than a $20 product with 50mg (5 doses).
  2. Consumption method efficiency: Different methods have vastly different bioavailability rates. Smoking and vaping typically deliver 10-35% of cannabinoids to your bloodstream, while edibles might deliver only 4-12% (but with longer-lasting effects). This efficiency directly affects the real cost per experience.
  3. Dispensary loyalty programs: Many retailers offer significant discounts (10-15%) for returning customers or first-time visitors. Taking advantage of these programs can substantially reduce costs without sacrificing quality.
  4. Targeted terpene profiles: Sometimes mid-priced products with specific terpene combinations (like myrcene for relaxation or limonene for mood elevation) offer precisely the effects a consumer wants without premium pricing.
  5. Transparency in testing: Reputable producers provide comprehensive lab results confirming not just potency but also terpene profiles and the absence of contaminants, pesticides, and heavy metals. This information helps ensure you're getting what you pay for.
  6. Harvest and package dates: Freshness significantly impacts quality, with properly stored cannabis maintaining optimal properties for about six months. Products approaching their one-year mark often sell at discount but may have diminished potency and terpene content.

Market Maturation: The New York Example

The evolution of cannabis pricing becomes clearer when examining maturing markets like New York. Recent data shows the average price for 3.5 grams of cannabis at New York dispensaries has fallen from $41.13 when legal sales launched in 2022 to $38.96 in early 2025. The price drops extend across product categories, with one gram of concentrate decreasing from $58.92 to $50.30 and one-gram vape products dropping from $64.89 to $55.35, according to a New York Office of Cannabis Management (OCM) analysis.

John Kagia, OCM's executive director of market policy, innovation, and analytics, attributes these shifts to increasing competition: "Retailers are adjusting their prices as part of their competitive strategy as more locations have opened. While it remains a little early to determine all the factors driving the retail price compression, it is common to see price compression as new markets mature and competition intensifies."

New York's cannabis ecosystem now features over 500 brands with approximately 370 retail locations, creating a competitive landscape that benefits consumers through lower prices. "Lower prices indicate a growing diversity of products available in the market," Kagia notes. "They increase affordability for consumers and enable the legal market to compete more effectively against the illicit market."

This market evolution has impacted dispensary revenues as well. While sales revenues per dispensary reached $599,000 in August 2024, by February 2025 that figure had dropped to $351,000 per store. Despite these per-location decreases, New York's overall cannabis market remains robust, with total sales reaching $1.46 billion since the launch of adult-use sales and on pace to hit $1.5 billion in 2025 alone.

The Future of Cannabis Pricing

As legal markets continue maturing nationwide, several trends are emerging:

  • Price normalization: Initial high prices in new markets typically decline as production scales up and competition increases, as demonstrated by New York's experience.
  • Quality stratification: Like wine or coffee markets, cannabis is developing distinct price tiers based on objective quality differences and production methods.
  • Consumer education: As buyers become more knowledgeable, pricing based purely on THC percentage or marketing hype becomes less effective.
  • Production efficiencies: Improved growing techniques and technology are helping producers deliver higher quality at lower cost.

A Market Finding Its Equilibrium

The legal cannabis industry continues evolving rapidly, with pricing structures that reflect its unique regulatory challenges, production complexities, and maturing consumer preferences. This evolution demonstrates classic economic principles at work, as markets move from novelty pricing toward equilibrium.

"We're witnessing what economists would call market normalization," says Dr. Beau Whitney, founder of Whitney Economics, a leading cannabis economic research firm. "The initial premium pricing we see in new markets reflects limited supply meeting pent-up demand, but with time, production capacity increases, competition intensifies, and prices tend to stabilize at levels that balance producer profitability with consumer affordability."

For shoppers navigating this complex landscape, understanding the factors behind cannabis pricing helps them make choices aligned with both their preferences and budgets. The education gap between newcomers and experienced consumers is narrowing as dispensary staff improve their ability to guide customers through the range of options.

Whether seeking budget-friendly options or premium craft cannabis, today's consumers benefit from unprecedented choice and transparency—a welcome change from the days when whatever the dealer had was the only option available. The industry's ongoing price evolution reflects not just changing consumer preferences and growing competition, but also cannabis's gradual transition from forbidden substance to mainstream consumer product.

Recent